Cross-sectional Selection of Time-Updated Characteristics by Statin and CVM Use (all patients under observation).

Hazard Ratio (95% CI) of first VF (n = 19,324 / 10, 534 failures).

Characteristics of HIV-infected vs. HIV-uninfected MSM and TW screened for participation in HPTN 075 (N = 601).

Factors associated with late initiation of maternal ARV.

Self- reported side-effects by study participants.

Prevalence of child and family psychosocial characteristics (N = 429).

Cost of GeneXpert scenario compared to 100% centralized scenario over 5 years in the overall population.

Since the early 1990s human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) emerged as a global health pandemic, with sub-Saharan Africa the hardest hit....

Size of HIV-positive population and % HIV-positive and receiving ARVs.

Daily cost of 2nd line ARVs for children.

Current biomedical interventions that are capable of bending the HIV epidemic curve.

Unit costs per staff encounter (USD 2012).

Incremental cost per opportunistic infection based on one-way sensitivity analyses.

Effectiveness of GeneXpert scenario compared to 100% centralized scenario over 5 years in the child population.

Factors associated with infant mortality (n = 1553).

Select demographic and behavioral characteristics of study participants (n = 47).

Ratio of bites and PEP.

(* p<0.05). HIV+ Malaria + omitted from graphs (2A and 2B) because of small sample size.

Comorbidities and co-infections reported by study participants.

Annual number of new HIV infections in children and adults.